2 Followers on Owler

Aviceda

is a Massachusetts-based clinical-stage biotechnology company that researches and develops novel therapies for the treatment of chronic non-resolving inflammation... Read more
OverviewCompetitorsFundingNews & Insights

Aviceda

is a Massachusetts-based clinical-stage biotechnology company that researches and develops novel therapies for the treatment of chronic non-resolving inflammation... Read more
Aviceda President & CEO: Jeffrey Nau

President & CEO

Jeffrey Nau

CEO Approval Rating

- -/100

2019

PrivateIndependent Company

Pharmaceuticals & Biotechnology
Biotechnology

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
25-100
Agree?
Funding
$256.6M

News

Leadership Change
Apr 01, 2025
Citybizlist
Jeffrey Nau joined Aviceda as President & CEO
Funding
Jan 08, 2025
GlobalNewswire
Aviceda received $207.5M in Series C Funding

Aviceda Competitors

1Immunovant
2Evommune
3NodThera
4Sutro Biopharma
5Ventyx
6Cue Biopharma
7Sitryx
8ImmuPharma
9Artax Biopharma
10ValenzaBio
Unlock 20 + competitors

Trending Companies